Stay updated with breaking news from Nasdaq Kmph. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com started coverage on shares of Zevra Therapeutics (NASDAQ:KMPH – Get Rating) in a research report sent to investors on Sunday morning. The firm issued a hold rating on the specialty pharmaceutical company’s stock. Zevra Therapeutics Stock Performance Zevra Therapeutics has a 52-week low of $4.00 and a 52-week high of $6.92. The firm has […]
StockNews.com began coverage on shares of Zevra Therapeutics (NASDAQ:KMPH – Get Rating) in a research report released on Sunday. The brokerage issued a hold rating on the specialty pharmaceutical company’s stock. Zevra Therapeutics Price Performance Zevra Therapeutics has a one year low of $4.00 and a one year high of $6.92. The company has a […]
StockNews.com began coverage on shares of Zevra Therapeutics (NASDAQ:KMPH – Get Rating) in a research report released on Saturday. The firm issued a hold rating on the specialty pharmaceutical company’s stock. Zevra Therapeutics Stock Down 0.3 % Zevra Therapeutics stock opened at $5.81 on Friday. The stock has a 50-day moving average of $5.41 and […]
StockNews.com initiated coverage on shares of Zevra Therapeutics (NASDAQ:KMPH – Get Rating) in a report issued on Saturday. The firm set a “hold” rating on the specialty pharmaceutical company’s stock. Zevra Therapeutics Price Performance Shares of KMPH stock opened at $5.81 on Friday. Zevra Therapeutics has a 12-month low of $4.00 and a 12-month high […]
CELEBRATION, Fla., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: KMPH) (“Zevra” or the “Company” and formerly known as KemPharm,...